FDA Inspection
Zhejiang Haisen Pharmaceutical Co., Ltd.Zhejiang Haisen Pharmaceutical Co., Ltd. – FDA Inspection, Apr 21, 2017
Record Details
This FDA Inspection record concerns Zhejiang Haisen Pharmaceutical Co., Ltd., with an inspection on April 21, 2017, issued by the Center for Veterinary Medicine, covering veterinary.
- Person
- Reba A. Gates (Issuing Officer)
View Company Profile
ID · e49decd9-c56a-4a65-a8b0-e3a6318dfd78
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1013039
- FDA center
- Animal Drugs & Feeds
- Project area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Haisen Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 15, 2024 | Not classified | Office of Inspections and Investigations | |
| April 11, 2018 | OAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
| December 12, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Haisen Pharmaceutical Co., Ltd.
- FDA Inspection 1255806 - 2024-11-15
- FDA Inspection 1049416 - 2018-04-11
- FDA Inspection 910004 - 2014-12-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.